We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Justin A. Boyd
Justin A. Boyd
Products
PRODUCTS
Pfizer Asia Pacific Pte., Ltd.
Justin A. Boyd
Price:
$117.00
View
MSD International GmbH (Singapore Branch)
Justin A. Boyd
Price:
$117.00
View
Glenmark Pharmaceuticals, Ltd.
Justin A. Boyd
and
Rita K. Kabaso
Price:
$117.00
View
Glenmark Pharmaceuticals, Ltd.
Justin A. Boyd
and
Rita K. Kabaso
Price:
$117.00
View
Pfizer Asia Pacific Pte. Ltd.
Justin A. Boyd
Price:
$117.00
View
MSD lntemational GmbH
Justin A. Boyd
Price:
$117.00
View
Baxalta Manufacturing Sarl
Justin A. Boyd
and
Timothy K Lee
Price:
$117.00
View
Adello Biologies LLC
Justin A. Boyd
,
Merry Christie
, and
Christopher D. Leach
Price:
$117.00
View
GSK Vaccines GmbH
Justin A. Boyd
and
Mihaly S. Ligmond
Price:
$117.00
View
ADMA Biologics, Inc.
Justin A. Boyd
and
Michele L. Forster
Price:
$117.00
View
View All Products by Justin A. Boyd
Upcoming Events
15
Apr
Five Telltale Signs You’re Ready for an Electronic TMF System
21
Apr
CDER’s Most Significant Guidance Priorities for 2021: Biosimilars/Biologics, Generics/Exclusivity, Real-World Evidence, Drug Development and Digital Health
26
Apr
MAGI's Clinical Research vConference — Spring 2021
06
May
The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
UK’s NICE Rejects Opdivo and Yervoy Combo for Lung Cancer
Medtronic Earns De Novo Clearance for AI Colonoscopy System
Health Canada Introduces New Reporting Requirements to Reduce Shortages
Gilead Halts Phase 3 Remdesivir Study in High-Risk Nonhospitalized COVID-19 Patients
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
